2011
DOI: 10.1016/j.jss.2010.01.025
|View full text |Cite
|
Sign up to set email alerts
|

Cepharanthine Improves Renal Ischemia-Reperfusion Injury in Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 20 publications
0
8
0
Order By: Relevance
“…It was used for the treatment of various diseases such as the inhibition of free radicals, radiation-induced leukopenia, venomous snakebites, etc. [87,88]. At 30 µg/mL, cepharanthine had the ability of 94.6% inhibition on the peroxidation of linoleic acid [89].…”
Section: Antioxidant Activitiesmentioning
confidence: 96%
“…It was used for the treatment of various diseases such as the inhibition of free radicals, radiation-induced leukopenia, venomous snakebites, etc. [87,88]. At 30 µg/mL, cepharanthine had the ability of 94.6% inhibition on the peroxidation of linoleic acid [89].…”
Section: Antioxidant Activitiesmentioning
confidence: 96%
“…Intraperitoneal injection of vehicle or cepharanthine was performed immediately before reperfusion or at comparable time point in the sham groups. The dose of cepharanthine was determined according to previous reports [ 15 , 19 ].…”
Section: Methodsmentioning
confidence: 99%
“…Recent studies have demonstrated the beneficial effects of cepharanthine on several experimental models of inflammation [ 15 18 ]. Moreover, a recent study revealed that cepharanthine could attenuate acute kidney injury in a rat model of local renal I/R [ 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…CPA has been widely used for the treatment of many acute and chronic diseases, such as venomous snakebite, alopecia areata, exudative otitis media, and endotoxic shock (Furusawa & Wu 2007 ; Kusaka et al. 2011 ; Rogosnitzky & Danks 2011 ). CPA also exhibits potent anticancer activity in vitro for different cancer cells (Biswas et al.…”
Section: Introductionmentioning
confidence: 99%